• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

First-Ever Brain Implant To Treat OCD And Epilepsy Proves “Life-Changing” For Patient

February 6, 2024 by Deborah Bloomfield

A 34-year-old woman in the US has become the first person to receive a brain implant that treats both epilepsy and obsessive compulsive disorder (OCD). Having been fitted with the device at Oregon Health and Science University in Portland, Amber Pearson says her incessant hand-washing and anxiety about contamination have now all but vanished.

Measuring 32 millimeters (about an inch) in length, the chip – known as a responsive neurostimulation system (RNS) – was originally offered to Pearson as a treatment for her epilepsy. Such implants are commonly used for the condition, and work by delivering a pulse that disrupts brain activity patterns associated with seizures.

Advertisement

Speaking to AFP, Pearson’s neurosurgeon Ahmed Raslan explained that “It was her idea to say, ‘well, you’re going into my brain and putting this wire, and I have OCD, so can you just put a wire for OCD?’.”

“And you know, luckily, we took that suggestion seriously.”

To configure the RNS, doctors recorded the brain activity patterns that arose when Pearson was exposed to seafood – a trigger that tends to set off her compulsions. They were then able to program the device to recognize and disrupt these signals, in addition to those linked to epileptic seizures.

“Usually we think of devices either for OCD or for epilepsy”, said Raslan. Pearson’s implant, however, is “the only device in the world that treats two conditions.”

Advertisement

“And it’s programmed independently. So the program for epilepsy is different than the program for OCD,” explained the neurosurgeon.

After being fitted with the device in March 2019, Pearson had to wait around eight months to start seeing noticeable results. However, at her final follow-up two-and-a-half years later, she told doctors that the RNS had transformed her life.

Tracking her progress over that period, the authors of a case report write that “she has had a life-changing improvement in her OCD symptoms.” For instance, they explain that she now spends no more than 30 minutes a day on “compulsions” like excessive hand-washing or checking that windows are closed – activities that used to rob her of more than eight hours a day.

The researchers state that Pearson in now “able to do things that she had previously deemed impossible, such as being able to sit next to someone eating something that previously would have triggered her contamination obsessions (e.g., seafood) and to leave the house without engaging in much of her previous checking routine, such that she is no longer late for work.” 

Advertisement

“She has also resumed living independently for the first time in many years,” they write.

In a statement, Pearson herself explained that “OCD is worse than having the seizures.” Describing how she used to wash her hands until they bled, she says that “epilepsy brings limitations to my life, but OCD controlled it.”

However, thanks to the RNS, things have improved dramatically. “I’m actually present in my daily life and that’s incredible,” she told AFP. “Before, I was just constantly in my head worrying about my compulsions.”

The case report is published in the journal Neuron.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Exclusive-Warburg Pincus seeks $16 billion for private equity fund -sources
  2. Vaping Linked To Heart Damage, Making It Unsafe Alternative To Smoking
  3. Cardiovascular Device Market Size is Expected to Reach Over USD 104.7 Bn by 2032 | CAGR 6.4%
  4. Fossil Frogs Dating Back 10 Million Years Become The World’s First Gingers

Source Link: First-Ever Brain Implant To Treat OCD And Epilepsy Proves "Life-Changing" For Patient

Filed Under: News

Primary Sidebar

  • The “Eyes Of Clavius” Will Be Visible On The Moon Today, Thanks To Clair-Obscur Effect
  • Shockingly High Microplastic Levels Found On Remote Mediterranean Coral Reef Island
  • Interstellar Object, Cheesy Nightmares, And Smooching Orcas
  • World’s Largest Martian Meteorite Up For Auction Could Reach Whopping $2-4 Million
  • Kimalu The Beluga Whale Undergoes Pioneering Surgery And Becomes First Beluga To Survive General Aesthetic
  • The 1986 Soviet Space Mission That’s Never Been Repeated: Mir To Salyut And Back Again
  • Grisly Incident In Yellowstone National Park Shows Just How Dangerous This Vibrant Wilderness Can Be
  • Out Of All Greenhouse Gas Emitters On Earth, One US Organization Takes The Biscuit
  • Overly Ambitious Adder Attempts To Eat Hare 10 Times Its Mass In Gnarly Video
  • How Fast Does A Spacecraft Need To Go To Escape The Solar System?
  • President Trump’s Cuts To USAID Could Result In A “Staggering” 14 Million Avoidable Deaths By 2030
  • Dzo: Hybrids Beasts That Are Perfectly Crafted For Life On Earth’s Highest Mountains
  • “Rarest Event Ever” Had A Half-Life 1 Trillion Times Longer Than The Age Of The Universe – How Did We See It?
  • Meet The Bille, A Self-Righting Tetrahedron That Nobody Was Sure Could Exist
  • Neurogenesis Confirmed: Adult Brains Really Do Make New Hippocampal Neurons
  • RFK Jr Suggested Letting Bird Flu Run Through Farms – Experts Still Think It’s A Bad Idea
  • “For Unknown Reasons”: Mystery Of The Oldest Human Remains Ever Found In Antarctica
  • Alaska’s Wilderness At Risk As Trump Opens “Up To 82 Percent” Of National Reserve To Drilling
  • “Life-Changing” Gene Therapy Restores Hearing In Deaf Patients Within Weeks After Just One Shot
  • Man Broke Down Wall In His Basement And Discovered An Ancient Underground City That Once Housed 20,000 People
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version